Related Experiment Video

Updated: May 10, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

[Role of continuous subcutaneous glucose monitoring in intensive care]

Gábor Marics1, Levente Koncz, Anna Körner

  • 1Semmelweis Egyetem, Általános Orvostudományi Kar I. Gyermekgyógyászati Klinika Budapest. marics.gabor@gmail.com

Orvosi Hetilap
|July 3, 2013
PubMed

Insights

Close glucose monitoring in intensive care units is crucial. Subcutaneous continuous glucose monitoring (SCGM) offers an alternative, but its reliability in critical care, especially in pediatric patients, requires further investigation due to potential inaccuracies.

Area of Science:

  • Critical care medicine
  • Endocrinology
  • Pediatrics

Context:

  • Stress hyperglycemia management in intensive care units (ICUs) has evolved, with strict glycemic control showing mortality benefits.
  • However, aggressive glycemic control can lead to hypoglycemia, particularly risky in pediatric patients due to their developing central nervous system.
  • Close glucose level monitoring is therefore essential in ICUs.

Purpose:

  • To evaluate the utility and limitations of subcutaneous continuous glucose monitoring (SCGM) as an alternative to traditional blood glucose measurements in intensive care settings.
  • To assess the reliability of SCGM, specifically the Medtronic system, considering its application in critically ill patients.

Summary:

  • While SCGM presents a potential alternative for glucose monitoring in ICUs, its accuracy can be compromised by factors like decreased tissue perfusion, as measurements are taken from interstitial fluid.
  • The pediatric population faces a heightened risk of hypoglycemia, making precise glucose monitoring paramount.
  • Current data on SCGM reliability in ICUs is insufficient to recommend routine use.

Impact:

  • Highlights the need for further research into SCGM's accuracy and reliability in diverse ICU populations, including children.
  • Informs clinical practice regarding the current limitations of SCGM in critical care settings.
  • Contributes to the ongoing discussion on optimizing glycemic management in intensive care to improve patient outcomes.

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...